Key result
Coronary artery calcification remains linked to poor cardiovascular prognosis despite modern medical therapy and revascularization.
Why the study?
Coronary artery calcification is a risk factor for adverse outcomes and current medical therapies have not successfully controlled its progression.
Answers are grounded in this paper and cite their sources.
Coronary artery calcification remains a significant risk factor for adverse outcomes with limited effective medical or device-based therapies currently available.
Coronary artery calcification (CAC) is a risk factor for adverse outcomes in the general population and in patients with coronary artery disease. The pathogenesis of CAC and bone formation share common pathways, and risk factors have been identified that contribute to the initiation and progression of CAC. Efforts to control CAC with medical therapy have not been successful. Event-free survival is also reduced in patients with coronary calcification after both percutaneous coronary intervention (PCI) and bypass graft surgery. Although drug-eluting stents and devices for plaque modification have modestly improved outcomes in calcified vessels, adverse event rates are still high. Innovative pharmacologic and device-based approaches are needed to improve the poor prognosis of patients with CAC.
No takes yet. Share an insight, caveat, or question.
Madhavan et al. (2014) conducted a review in Coronary artery calcification. Coronary artery calcification remains a significant risk factor for adverse outcomes with poor prognosis despite current medical therapies and revascularization techniques.
Synapse has enriched 10 related papers. Consider them for comparative context: